LINTHICUM, Md., March 1, 2006 (PRIMEZONE) -- Dialysis Corporation of America (Nasdaq:DCAI) announced the acquisition of two dialysis centers, located in Baltimore and Arnold, Maryland. The two centers, each located within skilled nursing facilities, have a combined total of twelve treatment stations, and currently treat approximately 65 patients. Both facilities are designed with the ability to serve patients within the facilities they are located, as well as patients from the surrounding communities. The company, through the formation of a limited liability company, purchased the assets of the facilities from a local nephrologist.
President and CEO Stephen Everett commented, "Maryland has proved to be a solid market for DCA, and we are thrilled to be expanding our presence in the greater Baltimore/Washington DC area. This opportunity has provided our company with an expanded patient base in the region, as well as the establishment of new relationships with area nephrologists previously unassociated with DCA."
Dialysis Corporation of America currently owns or manages 29 free standing kidney hemodialysis centers in Pennsylvania, New Jersey, Georgia, Ohio, Maryland, Virginia and South Carolina providing patients with a full range of quality in-center, and at-home hemodialysis services, as well as providing in-hospital services in many of our markets. With the completion of the five centers under development, DCA will have 34 centers in operation.
This release contains forward-looking statements that are subject to risks and uncertainties that could affect the business and prospects of the company and cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, growth and profitability not being able to be maintained, delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment, development and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of the company's dialysis facilities can mature to provide profitability, the extensive regulation of dialysis operations, government rate determination for Medicare reimbursement, and other risks detailed in the company's filings with the SEC, particularly as described in the company's proxy statement/prospectus dated August 12, 2005, and in its annual report on Form 10-K/A-1 for the fiscal year ended December 31, 2004.
The company's press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the SEC are available on Dialysis Corporation of America's Internet home page: http://www.dialysiscorporation.com.